Peer-influenced content. Sources you trust. No registration required. This is HCN.
Psychiatry & Behavioral Health Learning Network
In the digital age, AI isn’t just a buzzword; it’s the key to unlocking efficiency, reducing costs, and transforming patient care in behavioral health.
Psychiatry November 28th 2023
Psych Congress Network
The study suggests that although unlicensed doses may lead to additional symptom reduction, the gains are small and come with an increased risk of adverse events.
Psychiatry November 14th 2023
MDLinx
The potential benefits of shadow work could be profound for those willing to give it a try. This technique, which involves exploring suppressed aspects of one’s personality, can lead to increased self-awareness and emotional healing.
The advent of zuranolone may be going beyond postpartum depression, with 87.5% of patients noticing improvements within the first week of treatment for MDD.
The New England Journal of Medicine
The FDA’s guidance on psychedelic medicine is a landmark in mental health treatment. With the potential to treat PTSD, addiction, and treatment-resistant depression, psychedelics could heighten the field. However, the guidance also highlights the need for rigorous study of these substances, particularly regarding their subjective effects and the role of psychological support.
With catatonia’s prevalence estimates ranging from 9 to 30% in psychiatric emergency rooms and inpatient units, it’s crucial for healthcare professionals to be well-versed in its varied presentations and treatments.